PMID: 6982502Mar 1, 1982Paper

Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs

Scandinavian Journal of Gastroenterology
M Døssing, P B Andreasen

Abstract

During the decade 1968-1978 the Danish Board of Adverse Reactions to Drugs received 572 (6% of the total number) reports on hepatotoxicity. Halothane amounted to one fourth of the reported cases. Among the 94 psychotropic-induced adverse drug reactions 54 cases were attributed to chlorpromazine, 10 to tricyclic antidepressants, and only 2 to benzodiazepines. Considering the drug consumption data, the combination trimethoprim-sulfamethoxazole is nearly five times more frequently associated with hepatotoxicity than administration of sulfamethizole. Almost two thirds of the hepatotoxic reactions were classified as cytotoxic. Halothane, oxyphenisatin, rifampicin, alfa-methyldopa, papaverine, phenytoin, and ajmaline were almost exclusively related to cytotoxic reactions. Excluding the halothane-induced hepatotoxic reactions, the relative mortality of the cytotoxic (6%) reactions is not significantly different from that of the cholestatic (3%) ones. Thirteen percent of the patients with halothane-induced hepatotoxicity died.

References

Jan 1, 1978·Chemotherapy·J LlorensR Sanchez
Mar 1, 1969·British Medical Journal·N Hurwitz, O L Wade

❮ Previous
Next ❯

Citations

Aug 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J MuñozW C Maddrey
Oct 1, 1986·Acta Anaesthesiologica Scandinavica·D ZaricL Ranek
Jul 23, 2004·Expert Opinion on Drug Safety·Raúl J AndradeRocío González-Grande
Feb 18, 2011·Digestive Diseases and Sciences·Albert J Czaja
Nov 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christine M Hunt
Jan 29, 2013·Journal of Clinical Pharmacy and Therapeutics·M Sistanizad, G M Peterson
Apr 18, 2015·Scandinavian Journal of Gastroenterology·Einar S Björnsson, Anders Ekbom
Jan 1, 1989·DICP : the Annals of Pharmacotherapy·M A Smythe, G S Umstead
Aug 1, 1997·Journal of Clinical Psychopharmacology·M HummerW W Fleischhacker
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Catherine SgroPatrick Hillon
Jan 1, 1986·Acta Medica Scandinavica·J J Rumessen
Jan 30, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Clara AbrahamAlfred L Baker
Sep 11, 2008·The Annals of Pharmacotherapy·Sridhar SrinivasanJoseph A Fontana
Jun 12, 2012·BMC Gastroenterology·David Sprague, Kiran Bambha
Dec 22, 2012·Pharmacoepidemiology and Drug Safety·Janet ShinT Craig Cheetham
Dec 30, 2014·Journal of Pharmacy Practice·Manny Saltiel
Oct 3, 1999·Journal of Clinical Psychopharmacology·A B WhitworthW W Fleischhacker
Jul 1, 1985·Acta Anaesthesiologica Scandinavica·S OtsukaT Akaza
Apr 2, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sabrina CrepinMarie-Laure Laroche
May 9, 2021·BMJ Case Reports·Himmat Singh Brar, Rachana Marathi
Mar 23, 2000·Journal of Hepatology·D Larrey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.